Short Memories

Yesterday, after 7 continuous days of not been able to sleep, I finally succumb to fatigue. I did have pockets of sleep here and there but most of the nights, I am awake. So I watch some very boring movies in the hope to fall asleep but it did not help. I immediately suspended my pH rebalancing therapy for the time being.

As a precaution, I visited my family doctor and got some relaxant just in case I need it. I took a relaxant pill and then sleep like a baby. Today, I am back on my feet.

I incorporated my zeolite detox into the coffee enema program last Friday. On Saturday morning, I felt very week and it must have been the work of the zeolite I took on Friday. This is expected detox reaction and I should feel much better in the next few days. My enema discharge is now not only smelly, but has a fishy smell too.

Conventional Cancer Therapy
The money spend on cancer research is soaring each year and yet the cure that has been promised are still no where in sight. Every now and then, we hear of discoveries of potential cures. Our hearts are filled with hope when the researches describes their new findings. Many people have short memories and I would like to reproduce some statistics to remind them of the benefits that we have received from the billions that has been spent on cancer research over the last 50 years.

Now some statistics on a study of every randomized, controlled clinical trial from 1990 to 2004 in the US:

Cancer	Percent 5-year Survival
Bladder	00.0
Kidney	00.0
Melanoma	00.0
Multiple myeloma	00.0
Pancreas	00.0
Prostate	00.0
Soft tissue sarcoma	00.0
Unknown primary site	00.0
Uterus	00.1
Stomach	00.7
Colon	01.0
Breast	01.4
Head & Neck	01.9
Lung	02.0
Rectum	03.4
Brain	03.7
Esophagus	04.9
Ovary	08.9
Non-Hodgkin's lymp	10.5
Cervix	12.0
Testis	37.7
Hodgkin's disease	43.0

Source: Clinical Oncology (2004) 16: 549-560

As with so called new cures, I believe every cancer patient after reading the product brochure, would be willing to sell their houses and spent their entire fortune on the cure. A friend of my sister with stage 4 lung cancer just spent over RM390K (US$130K) on stem cells therapy in Japan three months ago. A few days back, she SMS me to ask if I have heard about the Sabah Snake Grass cure. So much for the stem cells therapy. Oh, I forgot to mentioned, she also spent a fortune on chemotherapy.

Just yesterday, a reader by the name of Nanay posted in my comments about another discovery by Japanese doctors about "Enzymes (macrophages) eating tumor cells". I am not saying this new therapy will not work, just that I am sure that these clinical trials would costs the patients hundred of thousand of dollars. Yet way back in 1967, Dr. William Donald Kelley, D.D.S., M.S. said in his ebook one answer to cancer that the tumor eating enzymes are produced by the pancreas and he provided detailed explanation about the pancreas and said "to protect the pancreas at all costs". This is the very organ which produces enzymes that kill tumor cells, so should we look elsewhere? How do you think healthy people keep cancer cells at bay? By the way Dr Kelley had pancreatic cancer, given two months to live but he cured himself. That's why I said we have short memories of forgetting the successes of the pioneers. Oh, I forgot to mentioned Dr Kelley's cure cannot be patented and only costs a few thousand dollars to follow.

America has the richest and most powerful cancer organisations (ACS and NCI) in the world. See how the money are spent on cancer research.

American Cancer Society: The World's Wealthiest "Nonprofit" Institution
In 1992, The Chronicle of Philanthropy reported that the ACS was "more interested in accumulating wealth than in saving lives." Fund-raising appeals routinely stated that the ACS needed more funds to support its cancer programs, all the while holding more than $750 million in cash and real estate assets. A 1992 article in the Wall Street Journal, by Thomas DiLorenzo, professor of economics at Loyola College and veteran investigator of nonprofit organizations, revealed that the Texas affiliate of the ACS owned more than $11 million worth of assets in land and real estate, as well as more than 56 vehicles, including 11 Ford Crown Victorias for senior executives and 45 other cars assigned to staff members. Arizona's ACS chapter spent less than 10 percent of its funds on direct community cancer services. In California, the figure was 11 percent, and under 9 percent in Missouri.

Thus for every $1 spent on direct service, approximately $6.40 is spent on compensation and overhead. In all ten states, salaries and fringe benefits are by far the largest single budget items, a surprising fact in light of the characterization of the appeals, which stress an urgent and critical need for donations to provide cancer services.

Nationally, only 16 percent or less of all money raised is spent on direct services to cancer victims, like driving cancer patients from the hospital after chemotherapy and providing pain medication. The intimate association between the ACS and the cancer drug industry, with current annual sales of about $12 billion, is further illustrated by the unbridled aggression which the Society has directed at potential competitors of the industry.

ACS maintains a "Committee on Unproven Methods of Cancer Management" which periodically "reviews" unorthodox or alternative therapies. This Committee is comprised of "volunteer health care professionals," carefully selected proponents of orthodox, expensive, and usually toxic drugs patented by major pharmaceutical companies, and opponents of alternative or "unproven" therapies which are generally cheap, nonpatentable, and minimally toxic.

NCI’s budget for FY 2009 was $4.97 billion, excluding the additional $1.26 billion in American Recovery and Reinvestment Act (ARRA) funds received by the Institute for spending in FY 2009 and FY 2010.

Overall, the NCI budget has been relatively flat in recent years. During the period from 2004 through 2009, NCI’s budget averaged $4.81 billion per year. In FY 2008, it was $4.83 billion; in FY 2007, it was $4.79 billion.

NCI Spending Each Year on Cancer Research

Cancer Type	2007 Spending (in millions)	2008 Spending (in millions)	2009 Spending (in millions)	2009 ARRA Spending (in millions)
Lung	$226.9	$247.6	$246.9	$48.0
Prostate	296.1	285.4	293.9	47.0
Breast	572.4	572.6	599.5	85.5
Colorectal	258.4	273.7	264.2	44.5
Bladder	19.8	24.1	25.9	2.8
Melanoma	97.7	110.8	103.7	17.6
Non-Hodgkin Lymphoma	113.0	122.6	130.9	14.0
Kidney	35.2	43.4	45.2	7.2
Leukemia	205.5	216.4	220.6	33.9
Pancreatic	73.3	87.3	89.7	10.7

50 over years have passed, where are the promised cures?